Barriers to optimal care for patients with coexisting substance use and mental health disorders

References

• Todd F C, Sellman J D, Robertson P J. The assessment and management of people with co-existing substance use and mental health disorders. ALAC, Wellington 1999
   Google Scholar
• Schuckit M A. Genetic and clinical implications of alcoholism and affective disorder. American Journal of Psychiatry 1986; 143: 140–147
   PubMed Web of Science ®Google Scholar
• Reich L H, Davies R K, Himmelhoch J M. Excessive alcohol use in manic-depressive illness. American Journal of Psychiatry 1974; 131: 83–86
   PubMed Web of Science ®Google Scholar
• Feinman J A, Dunner D L. The effect of alcohol and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders 1996; 37: 43–49
   PubMed Web of Science ®Google Scholar
• Keller M B, Lavori P W, Coryell W., et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. Journal of the American Medical Association 1986; 255: 3138–3142
   PubMed Web of Science ®Google Scholar
• Tien A Y, Anthony J C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 1990; 178: 473–480
   PubMed Web of Science ®Google Scholar
• Linszen D H, Dingemans P M, Lenior M E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 1994; 51: 273–279
   PubMed Web of Science ®Google Scholar
• Gruber A J, Pope H J, Brown M E. Do patients use marijuana as an antidepressant?. Depression 1996; 4: 77–80
   PubMedGoogle Scholar
• McLellan A T, Childress A R, Griffith J., Woody G E. The psychiatrically severe drug abuse patient: methadone maintenance or therapeutic community?. American Journal of Drug and Alcohol Abuse 1984; 10: 77–95
   PubMed Web of Science ®Google Scholar
• Rounsaville B J, Kosten T R, Weissman M M, Kleber H D. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Archives of General Psychiatry 1986; 43: 739–745
   PubMed Web of Science ®Google Scholar
• Gill K., Nolimal D., Crowley T J. Antisocial personality disorder, HIV risk behaviour and retention in methadone maintenance therapy. Drug and Alcohol Dependence 1992; 30: 247–252
   PubMed Web of Science ®Google Scholar
• Brooner R K, Greenfield L., Schmidt C W, Bigelow G E. Antisocial personality disorder and HIV infection among intravenous drug abusers. American Journal of Psychiatry 1993; 150: 53–58
   PubMed Web of Science ®Google Scholar
• Regier D A, Farmer M E, Rae D S, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. Journal of the American Medical Association 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Wittchen H., Bronisch T. Alcohol use, abuse and dependence in West Germany. Lifetime and six month prevalence in the Munich follow-up study. Alcoholism in North America, Europe and Asia, J E. Helzer, G J. Canino. Oxford University Press, New York 1992; 159–181
   Google Scholar
• Bland R C, Newman S C, Orn H. Alcohol abuse and dependence in Edmonton, Canada. Alcoholism in North America, Europe and Asia, J E. Helzer, G J. Canino. Oxford University Press, New York 1992; 97–112
   Google Scholar
• Russell J M, Newman S C, Bland R C. Drug abuse and dependence. Acta Psychiatrica Scandinavica 1995; 376((Suppl))54–62
   Google Scholar
• Helzer J E, Pryzbeck T R. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol 1988; 49: 219–224
   PubMed Web of Science ®Google Scholar
• Myers J K, Weissman M M, Tischler G L, et al. Six-month prevalence of psychiatric disorders in three communities 1980–82. Archives of General Psychiatry 1984; 41: 959–967
   PubMed Web of Science ®Google Scholar
• Tomasson K., Vaglum P. A nationwide representative sample of treatment-seeking alcoholics: a study of psychiatric comorbidity. Acta Psychiatrica Scandinavica 1995; 92: 378–385
   PubMed Web of Science ®Google Scholar
• Miller N. Psychiatric comorbidity: occurrence and treatment. Alcohol and Health Research World 1994; 18: 261–264
   PubMed Web of Science ®Google Scholar
• Goff D C, Henderson D C, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992; 149: 1189–1194
   PubMed Web of Science ®Google Scholar
• Chong S A, Choo H L. Smoking among Chinese patients with schizophrenia. Australian and New Zealand Journal of Psychiatry 1996; 309: 350–353
   Web of Science ®Google Scholar
• Drake R E, Bartels S J, Teague G B, Noordsy D L, Clark R E. Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease 1993; 181: 606–611
   PubMed Web of Science ®Google Scholar
• Mowbray C T, Solomon M., Ribisl K M, et al. Treatment for mental illness and substance abuse in a public psychiatric hospital. Successful strategies and challenging problems. Journal of Substance Abuse Treatment 1995; 12: 129–139
   PubMed Web of Science ®Google Scholar
• Shumway D L. Can managed behavioural health care plans serve the severely mentally ill?. Tomorrow March/April:, 1994; 41–48
   Google Scholar
• Carey K J. Substance use reduction in the context of outpatient psychiatric treatment. Community Mental Health Journal 1996; 32: 291–306
   PubMed Web of Science ®Google Scholar
• Osher F C, Kofoed L L. Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry 1989; 40: 1025–1030
   PubMedGoogle Scholar